Filing Details
- Accession Number:
- 0001567619-22-022096
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-29 16:06:32
- Reporting Period:
- 2022-12-27
- Accepted Time:
- 2022-12-29 16:06:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623715 | Imago Biosciences Inc. | IMGO | Pharmaceutical Preparations (2834) | 454915810 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755509 | Michael Arenberg | C/O Imago Biosciences, Inc. 303 Twin Dolphin Drive, 6Th Floor Redwood City CA 94065 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-27 | 28,206 | $15.45 | 53,101 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-27 | 66,794 | $18.44 | 119,895 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-27 | 70,508 | $35.93 | 49,387 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-27 | 28,206 | $0.00 | 28,206 | $15.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-27 | 66,794 | $0.00 | 66,794 | $18.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,149 | 2022-12-15 | 2032-11-07 | No | 4 | M | Direct |
| 304,206 | 2022-12-15 | 2032-03-22 | No | 4 | M | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $35.93 to $35.935, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
